Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Gormley

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
BMC Research Notes|August 28, 2009
The epidemiology of Guillain-Barré Syndrome in U.S. military personnel: a case-control studyLaura Nelson, Robert Gormley, Mark S Riddle, et al.
The American Journal of Gastroenterology|September 23, 2010
The Incidence and gastrointestinal infectious risk of functional gastrointestinal disorders in a healthy US adult populationChad K Porter, Robert Gormley, David R Tribble, et al.
Advances in Health Sciences Education : Theory and Practice|October 16, 2007
A natural language intelligent tutoring system for training pathologists: implementation and evaluationGilan M El Saadawi, Eugene Tseytlin, Elizabeth Legowski, et al.
The Journal of Infectious Diseases|June 22, 2014
A novel intramuscular bivalent norovirus virus-like particle vaccine candidate--reactogenicity, safety, and immunogenicity in a phase 1 trial in healthy adultsJohn J Treanor, Robert L Atmar, Sharon E Frey, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 31, 2006
AIDS and non-AIDS diffuse large B-cell lymphomas express different antigen profilesRashna Madan, Robert Gormley, Alina Dulau, et al.
Clinical and Vaccine Immunology : CVI|September 2, 2016
Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I StudyMark S Riddle, Robert W Kaminski, Claudio Di Paolo, et al.
Vaccine|September 26, 2020
A first in human clinical trial assessing the safety and immunogenicity of transcutaneously delivered enterotoxigenic Escherichia coli fimbrial tip adhesin with heat-labile enterotoxin with mutation R192GMark S Riddle, Milton Maciel, Chad K Porter, et al.
Vaccine|July 27, 2011
Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccineMark S Riddle, Robert W Kaminski, Carlos Williams, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
BMC Research Notes|August 28, 2009
The epidemiology of Guillain-Barré Syndrome in U.S. military personnel: a case-control studyLaura Nelson, Robert Gormley, Mark S Riddle, et al.
The American Journal of Gastroenterology|September 23, 2010
The Incidence and gastrointestinal infectious risk of functional gastrointestinal disorders in a healthy US adult populationChad K Porter, Robert Gormley, David R Tribble, et al.
Advances in Health Sciences Education : Theory and Practice|October 16, 2007
A natural language intelligent tutoring system for training pathologists: implementation and evaluationGilan M El Saadawi, Eugene Tseytlin, Elizabeth Legowski, et al.
The Journal of Infectious Diseases|June 22, 2014
A novel intramuscular bivalent norovirus virus-like particle vaccine candidate--reactogenicity, safety, and immunogenicity in a phase 1 trial in healthy adultsJohn J Treanor, Robert L Atmar, Sharon E Frey, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 31, 2006
AIDS and non-AIDS diffuse large B-cell lymphomas express different antigen profilesRashna Madan, Robert Gormley, Alina Dulau, et al.
Clinical and Vaccine Immunology : CVI|September 2, 2016
Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I StudyMark S Riddle, Robert W Kaminski, Claudio Di Paolo, et al.
Vaccine|September 26, 2020
A first in human clinical trial assessing the safety and immunogenicity of transcutaneously delivered enterotoxigenic Escherichia coli fimbrial tip adhesin with heat-labile enterotoxin with mutation R192GMark S Riddle, Milton Maciel, Chad K Porter, et al.
Vaccine|July 27, 2011
Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccineMark S Riddle, Robert W Kaminski, Carlos Williams, et al.
Pageof 1